Compliance Management

FDA Warns Against Kim Kardashian Drug Endorsement

Aug 12, 2015

WGNtv.com

An article in the Associated Press reported that the FDA said Kim Kardashian’s social media posts violated drug-promotion rules.

In her Instagram posts, Kardashian was touting the drug Diclegis, which is used to treat morning sickness. FDA says she violated drug promotion rules because she didn’t mention potentially dangerous side effects and drug interactions. The post has since been removed.

Read the full story and the FDA warning letter